Lack of association between the MDM2 promoter polymorphism SNP309 and clinical outcome in chronic lymphocytic leukimia

Lack of association between the MDM2 promoter polymorphism SNP309 and clinical outcome in chronic lymphocytic leukimia

The 309T>G polymorphism in the promoter region of the MDM2 gene, known as SNP309, has recently been suggested as an unfavorable prognostic marker in chronic lymphocytic leukemia (CLL) although this has been questioned. To investigate this further, we analyzed the MDM2 SNP309 genotypes in 418 CLL...

Cur síos iomlán

Sonraí bibleagrafaíochta
Príomhchruthaitheoirí: Kaderi, Mohd Arifin, Mansouri, Mahmoud, Zainuddin, Norafiza, Cahill, Nicola, Gunnarsson, Rebeqa, Jansson, Mattias, Kimby, Eva, Aleskog, Anna, Lundin, Jeanette, Glimelius, Bengt, Melbye, Mads, Juliusson, Gunnar, Jesper Jurlander, Jesper, Rosenquist, Richard
Formáid: Alt
Teanga:English
Foilsithe / Cruthaithe: Elsevier 2010
Ábhair:
RC254 Neoplasms. Tumors. Oncology (including Cancer)
Rochtain ar líne:http://irep.iium.edu.my/4408/1/Paper_III_Norafiza_Zainuddin.pdf

Ar líne

http://irep.iium.edu.my/4408/1/Paper_III_Norafiza_Zainuddin.pdf

Míreanna comhchosúla